参考文献/References:
[1]Kamada N,Chen GY,Inohara N,et al.Control of pathogens and pathobionts by the gut microbiota[J].Nat Immunol,2013,14(7):685-690.
[2]Fulde M,Hornef MW.Maturation of the enteric mucosal innate immune system during the postnatal period[J].Immunol Rev,2014,260(1):21-34.
[3]Ijssennagger N,Belzer C,Hooiveld GJ,et al.Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon[J].Proc Natl Acad Sci U S A,2015,112(32):10038-10043.
[4]Paparini DE,Choudhury RH,Vota DM,et al.Vasoactive intestinal peptide shapes first-trimester placenta trophoblast, vascular,and immune cell cooperation[J].Br J Pharmacol,2019,176(7): 964-980.
[5]Neuman H,Debelius JW,Knight R,et al.Microbial endocrinology: the interplay between the microbiota and the endocrine system[J].FEMS Microbiol Rev,2015,39(4):509-521.
[6]Yano JM,Yu K,Donaldson GP,et al.Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis[J].Cell,2015,161(2):264-276.
[7]Zarrinpar A,Chaix A,Xu ZZ,et al.Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism[J].Nat Commun,2018,9(1):2872.
[8]Canfora EE,Jocken JW,Blaak EE.Short-chain fatty acids in control of body weight and insulin sensitivity[J].Nat Rev Endocrinol,2015,11(10):577-591.
[9]Amato KR,Jeyakumar T,Poinar H,et al.Shifting Climates,Foods,and Diseases:The Human Microbiome through Evolution[J].Bioessays,2019,41(10):e1900034.
[10]Devlin AS,Fischbach MA.A biosynthetic pathway for a prominent class of microbiota-derived bile acids[J].Nat Chem Biol,2015,11(9):685-690.
[11]Haiser HJ,Gootenberg DB,Chatman K,et al.Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta[J].Science,2013,341(6143):295-298.
[12]Backhed F,Roswall J,Peng Y,et al.Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life[J].Cell Host Microbe,2015,17(6):852.
[13]Goodrich JK,Waters JL,Poole AC,et al.Human genetics shape the gut microbiome[J].Cell,2014,159(4):789-799.
[14]David LA,Maurice CF,Carmody RN,et al.Diet rapidly and reproducibly alters the human gut microbiome[J].Nature,2014,505(7484):559-563.
[15]Wang S,Charbonnier LM,Noval Rivas M,et al.MyD88 Adaptor-Dependent Microbial Sensing by Regulatory T Cells Promotes Mucosal Tolerance and Enforces Commensalism[J].Immunity,2015,43(2):289-303.
[16]Maurice CF,Haiser HJ,Turnbaugh PJ.Xenobiotics shape the physiology and gene expression of the active human gut microbiome[J].Cell,2013,152(1-2):39-50.
[17]Hsiao A,Ahmed AM,Subramanian S,et al.Members of the human gut microbiota involved in recovery from Vibrio cholerae infection[J].Nature,2014,515(7527):423-426.
[18]Zeevi D,Korem T,Zmora N,et al.Personalized Nutrition by Prediction of Glycemic Responses[J].Cell,2015,163(5):1079-1094.
[19]Shoaie S,Ghaffari P,Kovatcheva-Datchary P,et al.Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome[J].Cell Metab,2015,22(2):320-331.
[20]Dupont HL.Review article:evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets[J].Aliment Pharmacol Ther,2014,39(10): 1033-1042.
[21]Zhang FM,Li S,Ding L,et al.Effectiveness of mesalazine to treat irritable bowel syndrome:A meta-analysis[J].Medicine (Baltimore),2019,98(28):16297.
[22]Parthasarathy G,Chen J,Chen X,et al.Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms,Colonic Transit,and Methane Production in Female Patients With Chronic Constipation[J].Gastroenterology,2016,150(2):367-379,361.
[23]Sha S,Liang J,Chen M,et al.Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children[J].Aliment Pharmacol Ther,2014,39(10):1003-1032.
[24]Kunze WA,Mao YK,Wang B,et al.Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening[J].J Cell Mol Med,2009,13(8B):2261-2270.
[25]Collins SM,Denou E,Verdu EF,et al.The putative role of the intestinal microbiota in the irritable bowel syndrome[J].Dig Liver Dis,2009,41(12):850-853.
[26]Zhou Q,Zhang B,Verne GN.Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome[J].Pain,2009,146(1-2):41-46.
[27]Wirtz S,Neurath MF.Mouse models of inflammatory bowel disease[J].Adv Drug Deliv Rev,2007,59(11):1073-1083.
[28]Garrett WS,Lord GM,Punit S,et al.Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system[J].Cell,2007,131(1):33-45.
[29]Schafer C,Parlesak A,Schutt C,et al.Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein,soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease[J].Alcohol Alcohol,2002,37(1):81-86.
[30]Guarner C,Gonzalez-Navajas JM,Sanchez E,et al.The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation[J]. Hepatology,2006,44(3):633-639.
[31]Csak T,Velayudham A,Hritz I,et al.Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice[J]. Am J Physiol Gastrointest Liver Physiol,2011,300(3):G433-G441.
[32]Qin J,Li Y,Cai Z,et al.A metagenome-wide association study of gut microbiota in type 2 diabetes[J].Nature,2012,490(7418):55-60.
[33]Mehta NN,McGillicuddy FC,Anderson PD,et al.Experimental endotoxemia induces adipose inflammation and insulin resistance in humans[J].Diabetes,2010,59(1):172-181.
[34]Grivennikov SI,Wang K,Mucida D,et al.Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth[J].Nature,2012,491(7423):254-258.
[35]Liu S,Sun X,Wang M,et al.A microRNA 221-and 222-mediated feedback loop maintains constitutive activation of NFkappaB and STAT3 in colorectal cancer cells[J].Gastroenterology,2014,147(4):847-859,e811.
[36]Tosolini M,Kirilovsky A,Mlecnik B,et al.Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1,th2,treg,th17) in patients with colorectal cancer[J].Cancer Res,2011,71(4):1263-1271.
[37]Koren O,Spor A,Felin J,et al.Human oral,gut,and plaque microbiota in patients with atherosclerosis[J].Proc Natl Acad Sci U S A,2011,108(Suppl 1):4592-4598.
[38]Tang WH,Wang Z,Levison BS,et al.Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J].N Engl J Med,2013,368(17):1575-1584.
[39]Koeth RA,Wang Z,Levison BS,et al.Intestinal microbiota metabolism of L-carnitine,a nutrient in red meat,promotes atherosclerosis[J].Nat Med,2013,19(5):576-585.
[40]Zhu W,Gregory JC,Org E,et al.Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk[J].Cell,2016,165(1):111-124.
[41]Francavilla R,Calasso M,Calace L,et al.Effect of lactose on gut microbiota and metabolome of infants with cow's milk allergy[J].Pediatr Allergy Immunol,2012,23(5):420-427.
[42]Fujimura KE,Sitarik AR,Havstad S,et al.Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation[J].Nat Med,2016,22(10):1187-1191.
[43]MacFabe DF.Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders[J].Microb Ecol Health Dis,2015(26):28177.
[44]Tana C,Umesaki Y,Imaoka A,et al.Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome[J].Neurogastroenterol Motil,2010,22(5):512-519,e114-e115.